Cyclic helix B peptide inhibits ischemia reperfusion-induced renal fibrosis via the PI3K/Akt/FoxO3a pathway

Renal fibrosis is a main cause of end-stage renal disease. Clinically, there is no beneficial treatment that can effectively reverse the progressive loss of renal function. We recently synthesized a novel proteolysis-resistant cyclic helix B peptide (CHBP) that exhibits promising renoprotective effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Cheng, Cao, Ye, Zhang, Yi, Li, Long, Xu, Ming, Long, Yaqiu, Rong, Ruiming, Zhu, Tongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641348/
https://www.ncbi.nlm.nih.gov/pubmed/26554357
http://dx.doi.org/10.1186/s12967-015-0699-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641348/
https://www.ncbi.nlm.nih.gov/pubmed/26554357
http://dx.doi.org/10.1186/s12967-015-0699-2

Ejemplares similares